SERUM FORMULATION
Aura Lift
Peptide Renewal Serum
A 30 mL serum presentation with GHK-Cu 3% and SNAP-8 5% listed on the supplied packaging. Explore the formulation details below.
Catalog presentation. Commercial classification and availability require confirmation.
Final formulation, classification, and commercial availability are pending confirmation.
GHK-Cu 3% + SNAP-8 5% · 30 mL
SELECT YOUR PRESENTATION Catalog preview
TECHNICAL OVERVIEW
A serum formulation, with composition in focus.
A finished serum is a multi-component formulation. The declared ingredients must be distinguished from the carrier system, preservatives, and other constituents. A percentage does not establish the exact chemical form, stability, or analytical recovery of either named component.
The packaging reference identifies the presentation; lot-specific records are needed to evaluate the finished formulation. Commercial classification and final intended-use labeling remain unconfirmed.
Before laboratory work, obtain the exact identity, formulation, quantity basis, supplier safety data, and analytical records for the lot.
Specifications
- Catalog identity
- Aura Lift Peptide Renewal Serum
- Catalog classification
- Serum formulation / supplier specifications pending
- Available presentations
- GHK-Cu 3% + SNAP-8 5% · 30 mL
- Intended use
- Commercial classification and intended-use labeling require supplier confirmation.
- Quantity interpretation
- Listed amounts identify catalog presentations, not doses. Confirm the content basis in the supplier specification.
- Identity and formulation
- Product identity, physical form, composition, analytical results, and supplier handling specifications must be matched to the BioAura lot.
- Lot-specific analytical results
- Pending. No purity, potency, sterility, endotoxin, or third-party testing claim is verified for this preview.
- Storage and stability
- Pending supplier instructions. No storage temperature, shelf life, or opened-container period is assigned.
Documentation & material status
Lot-specific records have not been supplied for this preview. Product imagery and general research literature do not establish the properties of a BioAura lot.
SPECTechnical specificationPending supplier verification
Product identity, physical form, composition, analytical results, and supplier handling specifications must be matched to the BioAura lot.
COACertificate of analysisLot-matched COA pending
Review the matching lot identifier, analytical methods, acceptance criteria, measured results, units, and issuing laboratory. A purity percentage alone does not establish content, identity, or suitability.
SDSSafety & handling recordsSupplier documentation pending
Obtain the relevant safety data, handling precautions, storage conditions, stability information, and disposal requirements before laboratory work.
PRODUCT QUESTIONS
Frequently Asked Questions
Which details still need confirmation?
The supplied packaging identifies Aura Lift as a 30 mL serum and lists GHK-Cu 3% and SNAP-8 5%. The complete formulation, percentage basis, lot documentation, availability, and pricing still require supplier confirmation.
What does the listed presentation tell me?
GHK-Cu 3% + SNAP-8 5% · 30 mL. These are supplied catalog details. They do not specify an experimental concentration, dose, preparation procedure, or administration instruction.
Is commercial use confirmed?
Commercial classification, final labeling, formulation details, and availability have not been confirmed. This preview provides no treatment, consumption, application, or administration instructions.
Can I purchase through this preview?
No. Prices and shopping-bag interactions demonstrate the proposed store experience. Final prices, availability, shipping, and payment processing have not been activated.
CONTINUE EXPLORING